Did You Invest in Barclays BankCallable CMS Steepener Notes (Cusip: 06738KTB7), due September 30, 2031?
According to Barclays Bank Callable CMS Steepener Notes (Cusip: 06738KTB7):
The Notes will not be listed on any U.S. securities exchange or quotation system. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the Notes or determined that this free writing prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):
If you bought the structured product known as Barclays BankCallable CMS Steepener Notes (Cusip: 06738KTB7), due September 30, 2031, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.
Image credit: Tony Monblat via Flickr